Scarica l'app Stockscreener
2.02
2.02%
0.04
Dopo l'orario di chiusura:
2.02
Precedente Chiudi:
$1.98
Aprire:
$1.97
Volume 24 ore:
108.13K
Relative Volume:
0.73
Capitalizzazione di mercato:
$220.90M
Reddito:
-
Utile/perdita netta:
$-60.14M
Rapporto P/E:
-2.8471
EPS:
-0.7095
Flusso di cassa netto:
$-68.17M
1 W Prestazione:
-2.42%
1M Prestazione:
+22.80%
6M Prestazione:
-29.12%
1 anno Prestazione:
-47.80%
Intervallo 1D:
$1.97
$2.065
Intervallo di 1 settimana:
$1.65
$2.1689
Portata 52W:
$1.4299
$4.26
Ac Immune Sa Stock (ACIU) Company Profile
Confronta ACIU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.02 | 220.90M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-31 | Iniziato | BTIG Research | Buy |
| 2019-02-01 | Downgrade | UBS | Buy → Neutral |
| 2019-01-04 | Iniziato | UBS | Buy |
| 2018-04-05 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | Iniziato | Credit Suisse | Outperform |
| 2016-10-18 | Iniziato | Jefferies | Buy |
| 2016-10-18 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Ac Immune Sa Borsa (ACIU) Ultime notizie
Handelsbanken Fonder AB Trims Stake in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune SA Announces Executive Changes - MarketScreener
AC Immune SA Announces Leadership Changes in Development Team - TipRanks
AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31% - simplywall.st
Millennium Management LLC Sells 47,100 Shares of AC Immune SA (NASDAQ:ACIU) - Defense World
Promising Renewable Energy Stocks To Watch Now – June 9th - Defense World
Squarepoint Ops LLC Invests $118,000 in AC Immune SA (NASDAQ:ACIU) - Defense World
June 2025 Penny Stocks With Promising Potential - simplywall.st
Jane Street Group LLC Buys Shares of 24,283 AC Immune SA (NASDAQ:ACIU) - Defense World
Two Sigma Advisers LP Acquires Shares of 13,410 AC Immune SA (NASDAQ:ACIU) - Defense World
ACIUAC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - mx.advfn.com
Northern Trust Corp Makes New Investment in AC Immune SA (NASDAQ:ACIU) - Defense World
Individual investors among AC Immune SA's (NASDAQ:ACIU) largest shareholders, saw gain in holdings value after stock jumped 11% last week - simplywall.st
TRIALS UPDATE: The Latest Alzheimer’s Drug Development News (Q1 2025) - Being Patient
AC Immune SA Announces Board Changes Ahead of June 2025 AGM - TipRanks
Dimensional Fund Advisors LP Has $355,000 Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by StockNews.com - Defense World
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - ADVFN
AC Immune (ACIU) to Release Earnings on Monday - Defense World
AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks
AC Immune (NASDAQ:ACIU) Downgraded by StockNews.com to “Hold” - Defense World
Equities Analysts Issue Forecasts for AC Immune Q2 Earnings - Defense World
FY2027 EPS Estimates for AC Immune Cut by HC Wainwright - Defense World
HC Wainwright Lowers AC Immune (NASDAQ:ACIU) Price Target to $12.00 - Defense World
Planning For Perseverance - Life Science Leader
AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates - MSN
AC Immune (ACIU) Stock Rating Maintained, Price Target Lowered | - GuruFocus
H.C. Wainwright cuts AC Immune SA target to $12; maintains buy - Investing.com
AC Immune (ACIU) Target Price Reduced by H.C. Wainwright | ACIU Stock News - GuruFocus
AC Immune price target lowered to $12 from $16 at H.C. Wainwright - TipRanks
AC Immune: Q1 Earnings Snapshot - MySA
AC Immune reports Q1 EPS (19c) vs (18c) last year - TipRanks
AC Immune Reports Q1 2025 Financial Results - TipRanks
ACIU Surpasses Revenue Expectations with Strong Phase 2 Data | A - GuruFocus
AC Immune SA Reports Q1 2025 Financial Results and Clinical Advancements in Neurodegenerative Disease Therapies - Nasdaq
AC Immune Q1 Results: Breakthrough in Parkinson's Treatment Shows Promise, Cash Runway Extended to 2027 - Stock Titan
Precision Prevention: The Latest on Alzheimer’s Vaccines - Being Patient
Renaissance Technologies LLC Has $2 Million Stock Position in AC Immune SA (NASDAQ:ACIU) - American Banking and Market News
Individual investors in AC Immune SA (NASDAQ:ACIU) are its biggest bettors, and their bets paid off as stock gained 11% last week - Yahoo Finance
Wells Fargo & Company MN Lowers Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World
Is tau approaching a tipping point in Alzheimer’s drug development? - BioCentury
Q2 Earnings Estimate for AC Immune Issued By Leerink Partnrs - Defense World
Q1 Earnings Estimate for AC Immune Issued By Leerink Partnrs - Defense World
AC Immune unveils first-in-class Morphomer targeting pathological α-synuclein - BioWorld MedTech
ADPD 2025: Novel treatment modalities in neurodegenerative disorders - BioWorld MedTech
Ac Immune Sa Azioni (ACIU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):